Sylvain Vigneault

Country Manager, Australia

Sylvain Vigneault is the Country Manager for Viatris Australia. Overseeing the strategic direction of the business, he is responsible for leading a team of almost 800 employees Australia wide and supporting them to supply patients with access to more than 1,000 medicines.

Throughout 2020-2021, Sylvain guided the business through the transition to Viatris, which was formed through the combination of Mylan and Upjohn, a legacy division of Pfizer at the height of the COVID-19 pandemic.

Prior to this appointment, Sylvain held the role of Country Manager for Australia and Head of Commercial for New Zealand at Mylan for almost six years, following Mylan’s acquisition of Abbott EPD in 2015. Sylvain came to Australia in 2012 and was appointed General Manager Australia & New Zealand for Abbott EPD, based in Sydney.

In 2010, Sylvain started in the role of Commercial Director, RICC (Russia, India, China & CIS), where he led the development of the long-term strategy for the Cardiovascular and Vaccine portfolio. Sylvain has also held positions as Solvay’s Senior Vice President Neuroscience within the Global Product Strategy Department in Hannover, Germany, and then subsequently in Basel Switzerland.

Sylvain’s career began in Canada, and he has held roles in Czech Republic, France, Germany, Switzerland and Singapore before coming to Australia. Sylvain has also held the role of Chair of the Generic and Biosimilar Medicines Association from March 2018 to October 2020.

Maria Mollica, Head of Sales - Primary & Speciality Care

Maria Mollica is the Head of Sales for Viatris Australia, with the responsibility for primary and specialty care. Mollica leads a team of sales representatives calling on general practitioners, specialists and allied health professionals.

Ludovic Laporte, Head Commercial Finance

Ludovic Laporte is the Head of Finance for Viatris ANZ. He oversees Controlling, FP&A, Commercial Operations & Strategic Analysis of the ANZ business. Prior to Viatris, Ludovic served as Regional Head of Finance at Mylan.

Ash Kuchel, Head of Marketing

Ash Kuchel is Head of Marketing for Viatris Australia, with responsibility for developing the marketing of key Viatris brands through insight-based strategy, ensuring the positioning and messaging resonates with key stakeholders to drive the quality use of medicine and deliver better health outcomes.

Georgina Davies, Head of Commercial Excellence

Georgina Davies is Head of Business Excellence ANZ at Viatris. Georgina works to bring the principles of business excellence to Viatris. She does this by applying a scientific approach to the way we do things to bring value to our customers.

Jim Margaritis, Head of Sales Pharmacy

Jim Margaritis is the Head of Sales Pharmacy & Institutional for Viatris Australia. He oversees multiple teams that are responsible for a significant portion of revenue. Jim has 18 years of experience in firms like Alphapharm & Amneal Pharma

Charbel Azzi, Head of Business Development

Charbel Azzi is the Head of Business Development, Strategic Partnerships and Sourcing for Viatris Australia. Charbel is on the Commercial Leadership Team responsible for the business strategic direction and guides a cross functional team to deliver a robust portfolio of internal and 3rd party products for the Australian business.

Prior to this appointment, Charbel was responsible for managing strategic partnerships with leading pharmaceutical companies. After 6 years of working in various community pharmacy settings, Charbel started with Alphapharm in 2006 as a sales representative and spent the majority of his 9 year tenure in sales as a Regional Business Manager. Charbel transitioned next to a marketing manager role leading the pharmacy channel marketing team.

Charbel completed a Bachelor of Pharmacy degree from The University of Sydney and began his career in community pharmacy in 2000. In 2012, he completed a Master of Business Administration from UNSW (AGSM). Charbel remains a NSW registered and practicing community pharmacist.